Zero The End Of Prostate Cancer - Cancer Science

Relevant Publications

Longitudinal varying coefficient single-index model with censored covariates.

Issue Release: 2024

Efficiency of FeO@ZIF-8 for the removal of Doxorubicin from aqueous solutions: equilibrium, kinetics and thermodynamic studies.

Issue Release: 2022

Scalable proximal methods for cause-specific hazard modeling with time-varying coefficients.

Issue Release: 2022

High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States Series.

Issue Release: 2020

Total anatomical reconstruction during robot-assisted radical prostatectomy: focus on urinary continence recovery and related complications after 1000 procedures.

Issue Release: 2019

Impact of PET acquisition durations on image quality and lesion detectability in whole-body Ga-PSMA PET-MRI.

Issue Release: 2017

The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy.

Issue Release: 2014

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Issue Release: 2014

Robot-assisted radical prostatectomy of clinical high-risk patients with prostate cancer: a controlled study of operative and short-term postoperative events.

Issue Release: 2013

Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radiotherapy in the treatment of prostate cancer after radical prostatectomy.

Issue Release: 2013

A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer.

Issue Release: 2007

Cryosurgical technique: assessment of the fundamental variables using human prostate cancer model systems.

Issue Release: 2007

Can we obtain better specimens with an end-cutting prostatic biopsy device?

Issue Release: 2005

Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain.

Issue Release: 2003

Impact of reporting delay and reporting error on cancer incidence rates and trends.

Issue Release: 2002

Prostate-specific antigen in prostate cancer: a case study in the development of a tumor marker to monitor recurrence and assess response.

Issue Release: 2002

Carotenoids affect proliferation of human prostate cancer cells.

Issue Release: 2001

Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.

Issue Release: 1990

Italian cancer figures, report 2013: Multiple tumours.

Issue Release: 0000

What Are the Challenges in Addressing Pollution-Related Cancer?

What Measures Can Be Taken to Prevent Unauthorized Access?

What Are the Advantages of Using Multi Organ Chips in Cancer Research?

Why are Surface Markers Important in Cancer?

What are the benefits of using natural preservatives?

What are Household Products?

What Role Does Technology Play in the Review Process?

How Do Endothelial Cells Contribute to Tumor Growth?

What is the prognosis for patients receiving this treatment?

How do M1 Macrophages Function in Cancer?

Partnered Content Networks

Relevant Topics